IL-7-dependent STAT1 activation limits homeostatic CD4 T cell expansion

Σχετικά έγγραφα
Τα ηπατικά επίπεδα του FOXP3 mrna στη χρόνια ηπατίτιδα Β εξαρτώνται από την έκφραση των οδών Fas/FasL και PD-1/PD-L1

Supplemental Table S1. Tumor specific networks are enriched with somatically mutated genes (taken from the database COSMIC)

Supplementary Figure 1. Therapeutic efficacy of combined NDV and anti-ctla-4 therapy is attenuated with a larger tumor challenge.

Supplementary Figure 1

Christopher Stephen Inchley, 2015

ΜΟΡΙΑΚΕΣ ΜΕΘΟΔΟΙ ΚΡΙΤΗΡΙΑ ΕΠΙΛΟΓΗΣ ΑΞΙΟΛΟΓΗΣΗ

ΠΑΝΕΠΙΣΤΗΜΙΟ ΙΩΑΝΝΙΝΩΝ ΑΝΟΙΚΤΑ ΑΚΑΔΗΜΑΪΚΑ ΜΑΘΗΜΑΤΑ

< (0.999) Graft (0.698) (0.483) <0.001 (0.698) (<0.001) (<0.001) 3 months (0.999) (0.483) (<0.001) 6 months (<0.

ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ ΣΤΙΣ «ΚΛΙΝΙΚΕΣ ΚΑΙ ΚΛΙΝΙΚΟΕΡΓΑΣΤΗΡΙΑΚΕΣ ΙΑΤΡΙΚΕΣ ΕΙΔΙΚΟΤΗΤΕΣ»

Simon et al. Supplemental Data Page 1

SABiosciences PCR Array Catalog #: PAHS-021 SA+ SCF 4h stimulaton AVG(Ct) Position Unigene Refseq Symbol Description shcontr shcontr-4h shgskβ A01

encouraged to use the Version of Record that, when published, will replace this version. The most /BCJ

TFDP2 TFDP1 SUMO1 SERTAD1 RPA3 RBBP8 RAD9A RAD17 RAD1 NBN MRE11A MNAT1 KPNA2 KNTC1 HUS1 HERC5 GTSE1 GTF2H1 GADD45A E2F4 DNM2 DDX11 CUL3 SKP2 RBL1 RB1

ΓΕΩΠΟΝΙΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΤΜΗΜΑ ΑΓΡΟΤΙΚΗΣ ΟΙΚΟΝΟΜΙΑΣ & ΑΝΑΠΤΥΞΗΣ

5.4 The Poisson Distribution.

ΑΡΙΣΤΟΤΕΛΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ ΤΜΗΜΑ ΟΔΟΝΤΙΑΤΡΙΚΗΣ ΕΡΓΑΣΤΗΡΙΟ ΟΔΟΝΤΙΚΗΣ ΚΑΙ ΑΝΩΤΕΡΑΣ ΠΡΟΣΘΕΤΙΚΗΣ

NES: normalized enrichment score (analyzed using KEGG pathway gene sets in the GSEA software); FDR:

ΚΥΠΡΙΑΚΟΣ ΣΥΝΔΕΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY 21 ος ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ Δεύτερος Γύρος - 30 Μαρτίου 2011

The effect of curcumin on the stability of Aβ. dimers

IL - 13 /IL - 18 ELISA PCR RT - PCR. IL - 13 IL - 18 mrna. 13 IL - 18 mrna IL - 13 /IL Th1 /Th2

Προσομοίωση BP με το Bizagi Modeler

Μελέτη της έκφρασης του ογκοκατασταλτικού γονιδίου Cyld στον καρκίνο του μαστού

Inferring regulatory subnetworks through the analysis of genome-wide expression profiles

Supplementary Table 1. Primer sequences used for RT-qPCR validation of the microarray data. Primer. direction. Forward

Supporting Information

Aluminum Electrolytic Capacitors

Group 2 Methotrexate 7.5 mg/week, increased to 15 mg/week after 4 weeks. Methotrexate 7.5 mg/week, increased to 15 mg/week after 4 weeks

Does anemia contribute to end-organ dysfunction in ICU patients Statistical Analysis

SUPPORTING INFORMATION

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 11/3/2006

ΕΦΑΡΜΟΓΗ ΕΥΤΕΡΟΒΑΘΜΙΑ ΕΠΕΞΕΡΓΑΣΜΕΝΩΝ ΥΓΡΩΝ ΑΠΟΒΛΗΤΩΝ ΣΕ ΦΥΣΙΚΑ ΣΥΣΤΗΜΑΤΑ ΚΛΙΝΗΣ ΚΑΛΑΜΙΩΝ

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 19/5/2007

HOMEWORK 4 = G. In order to plot the stress versus the stretch we define a normalized stretch:

Molecular evolutionary dynamics of respiratory syncytial virus group A in

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 24/3/2007

Optimizing Microwave-assisted Extraction Process for Paprika Red Pigments Using Response Surface Methodology

HOMEWORK#1. t E(x) = 1 λ = (b) Find the median lifetime of a randomly selected light bulb. Answer:

Contents Part I Psychoneuroimmunology and Systems Biology Mechanisms 1 From Psychoneuroimmunology to Personalized, Systems, and Dynamical Medicine

CHAPTER 25 SOLVING EQUATIONS BY ITERATIVE METHODS

519.22(07.07) 78 : ( ) /.. ; c (07.07) , , 2008

Aluminum Electrolytic Capacitors (Large Can Type)

Supplementary Table 1. Construct List with key Biophysical Properties of the expression

α α Pneumocystis jirovecii

BD Cytometric Bead Array Flex Set System

Mean bond enthalpy Standard enthalpy of formation Bond N H N N N N H O O O

Aquinas College. Edexcel Mathematical formulae and statistics tables DO NOT WRITE ON THIS BOOKLET

(1) Describe the process by which mercury atoms become excited in a fluorescent tube (3)

A strategy for the identification of combinatorial bioactive compounds. contributing to the holistic effect of herbal medicines

Statistics 104: Quantitative Methods for Economics Formula and Theorem Review

a 2,5 b 2,5 upplemental Figure 1 IL4 (4h) in Ja18-/- mice IFN-γ (16h) in Ja18-/- mice 1,5 1,5 ng/ml ng/ml 0,5 0,5 4ClPh PyrC 4ClPh PyrC

ΕΚΤΙΜΗΣΗ ΤΟΥ ΚΟΣΤΟΥΣ ΤΩΝ ΟΔΙΚΩΝ ΑΤΥΧΗΜΑΤΩΝ ΚΑΙ ΔΙΕΡΕΥΝΗΣΗ ΤΩΝ ΠΑΡΑΓΟΝΤΩΝ ΕΠΙΡΡΟΗΣ ΤΟΥ

Cellular Physiology and Biochemistry

Εργαστήριο Ανάπτυξης Εφαρμογών Βάσεων Δεδομένων. Εξάμηνο 7 ο

EE512: Error Control Coding

Supplementary Materials for. Kinetic and Computational Studies on Pd(I) Dimer- Mediated Halogen Exchange of Aryl Iodides

Math 6 SL Probability Distributions Practice Test Mark Scheme

[1] P Q. Fig. 3.1

Sampling Basics (1B) Young Won Lim 9/21/13

Electronic Supplementary Information (ESI)

1) Abstract (To be organized as: background, aim, workpackages, expected results) (300 words max) Το όριο λέξεων θα είναι ελαστικό.

ΕΠΙΔΡΑΣΗ ΤΗΣ ΧΡΗΣΗΣ ΕΛΑΙΟΠΛΑΚΟΥΝΤΑ ΣΤΗΝ ΔΙΑΤΡΟΦΗ ΤΩΝ ΑΙΓΩΝ ΔΑΜΑΣΚΟΥ ΩΣ ΠΡΟΣ ΤΗΝ ΠΟΣΟΤΗΤΑ ΚΑΙ ΠΟΙΟΤΗΤΑ ΤΟΥ ΠΑΡΑΓΟΜΕΝΟΥ ΓΑΛΑΚΤΟΣ

Queensland University of Technology Transport Data Analysis and Modeling Methodologies

MSM Men who have Sex with Men HIV -

NMBTC.COM /

PE CVVH PE+HP HP+CVVH HP+CVVH+PE CVVH. ENLAV of HCO - 3 ENLAV-HCO ± μmol /L HP+PE HP+CVVH HP+CVVH+PE

Supplementary Table 1. Primers used for RT-qPCR analysis of striatal and nigral tissue.

Πτυχιακή Εργασία Η ΠΟΙΟΤΗΤΑ ΖΩΗΣ ΤΩΝ ΑΣΘΕΝΩΝ ΜΕ ΣΤΗΘΑΓΧΗ

ΤΕΧΝΟΛΟΓΙΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΚΥΠΡΟΥ ΣΧΟΛΗ ΓΕΩΠΟΝΙΚΩΝ ΕΠΙΣΤΗΜΩΝ ΒΙΟΤΕΧΝΟΛΟΓΙΑΣ ΚΑΙ ΕΠΙΣΤΗΜΗΣ ΤΡΟΦΙΜΩΝ. Πτυχιακή εργασία

On a four-dimensional hyperbolic manifold with finite volume

Μειέηε, θαηαζθεπή θαη πξνζνκνίσζε ηεο ιεηηνπξγίαο κηθξήο αλεκνγελλήηξηαο αμνληθήο ξνήο ΓΗΠΛΩΜΑΣΗΚΖ ΔΡΓΑΗΑ

TABLE OF CONTENTS Page

Matrices and Determinants

Surface Mount Multilayer Chip Capacitors for Commodity Solutions

2 Composition. Invertible Mappings

Cite as: Pol Antras, course materials for International Economics I, Spring MIT OpenCourseWare ( Massachusetts

Πολιτιστικό Προφίλ Δήμου Κορυδαλλού

Probability and Random Processes (Part II)

«ΑΓΡΟΤΟΥΡΙΣΜΟΣ ΚΑΙ ΤΟΠΙΚΗ ΑΝΑΠΤΥΞΗ: Ο ΡΟΛΟΣ ΤΩΝ ΝΕΩΝ ΤΕΧΝΟΛΟΓΙΩΝ ΣΤΗΝ ΠΡΟΩΘΗΣΗ ΤΩΝ ΓΥΝΑΙΚΕΙΩΝ ΣΥΝΕΤΑΙΡΙΣΜΩΝ»

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS SCHOOL OF SCIENCE FACULTY OF INFORMATICS AND TELECOMMUNICATIONS

Πρόβλημα 1: Αναζήτηση Ελάχιστης/Μέγιστης Τιμής

ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΠΛΗΡΟΦΟΡΙΚΗΣ CYPRUS COMPUTER SOCIETY ΠΑΓΚΥΠΡΙΟΣ ΜΑΘΗΤΙΚΟΣ ΔΙΑΓΩΝΙΣΜΟΣ ΠΛΗΡΟΦΟΡΙΚΗΣ 6/5/2006

Areas and Lengths in Polar Coordinates

Fixed Inductors / AL TYPE


«ΧΑΡΑΚΤΗΡΙΣΜΟΣ ΜΕΤΑΓΡΑΦΙΚΩΝ ΜΟΝΟΠΑΤΙΩΝ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗΝ ΑΛΛΕΡΓΙΑ (ΑΝΑΦΟΡΑ)»

,,, (, ) , ;,,, ; -

Abstract... I. Zusammenfassung... II. 1 Aim of the work Introduction Short overview of Chinese hamster ovary cell lines...

Supplemental tables and figures

Synthesis and Biological Evaluation of Novel Acyclic and Cyclic Glyoxamide derivatives as Bacterial Quorum Sensing and Biofilm Inhibitors

Supporting information. Influence of Aerosol Acidity on the Chemical Composition of Secondary Organic Aerosol from β caryophyllene

Επίδραση της Συμβολαιακής Γεωργίας στην Χρηματοοικονομική Διοίκηση των Επιχειρήσεων Τροφίμων. Ιωάννης Γκανάς

Η Α ΕΝΟΫΠΟΦΥΣΗ: OI ΓΟΝΑ ΟΤΡΟΠΙΝΕΣ (FSH, LH) ΚΑΙ Η ΠΡΟΛΑΚΤΙΝΗ (PRL)

Characterization of the molecular networks that control pathogenic T-cell driven responses in Multiple Sclerosis using RNA-seq analysis software

Correction Table for an Alcoholometer Calibrated at 20 o C

Salmonella produce microrna-like RNA fragment Sal-1 in the infected cells to. facilitate intracellular survival

Section 8.3 Trigonometric Equations

ΜΟΡΙΑΚΕΣ ΤΕΧΝΙΚΕΣ ΠΡΑΓΜΑΤΙΚΟΥ ΧΡΟΝΟΥ ΣΠΑΝΑΚΗΣ ΝΙΚΟΣ

Test Data Management in Practice

Πανεπιστήμιο Κρήτης, Τμήμα Επιστήμης Υπολογιστών Άνοιξη HΥ463 - Συστήματα Ανάκτησης Πληροφοριών Information Retrieval (IR) Systems

Potential Dividers. 46 minutes. 46 marks. Page 1 of 11

Transcript:

Supplemental Material IL-7-dependent STAT1 activation limits homeostatic CD4 T cell expansion Cecile Le Saout 1, Megan A. Luckey 2, Alejandro V. Villarino 3, Mindy Smith 1, Rebecca B. Hasley 1, Timothy G. Myers 4, Hiromi Imamichi 1, Jung-Hyun Park 2, John J O Shea 3, H. Clifford Lane 1 and Marta Catalfamo 1,* 1 CMRS/Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD, USA. * Department of Microbiology and Immunology. Georgetown Universisty School of Medicine. Washington DC, USA. 2 Experimental Immunology Branch, CCR, NCI, NIH, Bethesda, MD, USA 3 Lymphocyte Cell Biology Section, NIAMS, NIH, Bethesda, MD, USA 4 Genomic Technologies Section, Research Technologies Branch, NIAID, NIH, Bethesda, MD, USA

Figure S1. STAT1 Tg mice exhibit similar T cell counts and differentiation profiles than WT littermates. (A) Schematic representation of the transgene construct of mouse STAT1 cdna under the control of the human CD2 enhancer/promoter used to generate transgenic (Tg) mice. (B) Total cellularity in LNs, spleen and thymus from WT (n= 16, black symbols) and STAT1 Tg (n= 16, red synbols) mice. (C) Absolute numbers of CD4 and CD8 T cells were enumerated in the LNs of both groups. (D) Gating strategy and percentages of naïve (Tn: CD44 low CD62L high ), central memory (Tcm: CD44 high CD62L high ), effector/effector memory (Teff/em: CD44 high CD62L low ) on gated CD3 + CD4 + and CD8 + lymphocytes in WT and STAT1 Tg littermates are shown. LN cells from WT and STAT1 Tg mice were analyzed by flow cytometry for expression of (E) IL-7Rα and (F) phosphorylated STAT1 after in vitro stimulation with rmifn-α4 (5 U/ml) or rmifn-γ (1 ng/ml) in CD4 and CD8 T cells. A nonparametric Mann-Whitney test was performed for comparisons between groups. Data from four independent experiments out of four, including an average of 4 mice per group, are presented as box and whisker plots showing the median value bounded by the first and third quartiles in the box, with whiskers extending to the minimum and maximum values. Figure S2. IL-7 induces a similar set of STAT1/IFN associated genes in WT and STAT1 Tg T cells. Sorted WT and STAT1 Tg CD4 (n=5 and n=4 respectively) and CD8 (n=6 and n=5 respectively) naïve T cells were treated and analyzed as described in Figure 3. Venn diagrams illustrate (A) the overlap between WT and STAT1 Tg DEGs in response to IL-7 or IFN-γ in CD4 and CD8 Naïve T cells; (B) the overlap between the DEGs in WT cells stimulated with IFN-γ (green) and the DEGs in STAT1 Tg (red) T cells stimulated with IL-7.

Figure S3. Overexpression of t-stat1 leads to an enrichment of STAT1/IFN genes in T cells stimulated with IL-7. Sorted WT (n= 3) and STAT1 Tg (n= 3) CD4 Naïve T cells were stimulated or not overnight with rmil-7 (2 ng/ml) or rmifn-γ (1 ng/ml). RNA was isolated and gene expression was measured by RNA-seq. Libraries were prepared with.25-1 µg of total RNA using the TruSeq RNA Sample Preparation Kit V2 and sequenced for 5 cycles with a HiSeq 25 instrument (Illumina). 5 bp reads were then mapped onto mouse genome build mm9 using TopHat and further processed using Cufflinks (1). Lists of differentially expressed gene transcripts (DEGs) by IL-7 or IFN-γ stimulation in WT and STAT1 Tg were selected based on gene expression changes of at least 2 fold compared to unstimulated cells. (A) Venn diagrams illustrate the overlap between WT (black) and STAT1 Tg (red) DEGs in response to IL-7 in CD4 Naïve T cells. (B) Venn diagrams illustrate the overlap between the DEGs in WT cells stimulated with IFN-γ (green) and the DEGs in WT (black) or STAT1 Tg (red) T cells stimulated with IL-7. (C) Gene expression of Bcl2, Cish, Cxcl1, Ifit1, Socs1, Bik, Ifi27 and Socs2 was measured by quantitative RT-PCR (Quantitect SYBR green PCR system, Qiagen). The primer sequences are presented in Table S9. Gene expression values were normalized to those of Hprt in the same sample and fold changes were calculated relative to unstimulated condition for each mouse. Data represent mean ± SE of the log 2 (Fold change) of triplicate samples in two independent experiments. A nonparametric Mann-Whitney test was performed for comparisons between WT (black symbols) and STAT1 Tg (red symbols) cells. Figure S4. STAT1 overexpression induces a distinct transcriptional program in CD4 T cells stimulated with IL-7. Sorted WT and STAT1 Tg CD4 Naïve T cells were treated and analyzed as described in Figure 3 (9 minutes stimulation) or Figure S3 (overnight stimulation). Lists of

DEGs. their log 2 (FC) and adjusted p values were generated for these cells and used as input in IPA software. A positive or negative z-score value indicates that a function is predicted to be increased or decreased in T cells stimulated with IL-7. All categories shown are significant (p <.5). (A) Bar graphs show the overall affected categories of diseases and biological functions predicted by IPA analysis in WT (black) and STAT1 Tg (red) CD4 T cells stimulated 9 minutes with IL-7. Top 1 activated annotations and the number of RNAs (#Mol) differentially expressed in each are listed in the tables. (B) Bar graphs represent the top 1 diseases or functions annotations associated to Cell Death and Survival, Cellular Growth and Proliferation and Hematological System Development and categories predicted by IPA analysis in theses conditions. (C) Bar graphs show the overall affected categories of diseases and biological functions predicted by IPA analysis in WT (black) and STAT1 Tg (red) CD4 T cells stimulated overnight with IL-7. Top 1 activated annotations and the number of RNAs (#Mol) differentially expressed in each are listed in the tables. (D) Bar graphs represent the top 1 diseases or functions annotations associated to Cell Death and Survival categorie predicted by IPA analysis in theses conditions. Figure S5. WT and STAT1 Tg donor T cells exhibit similar responses to IL-7 through STAT5 and to IFN-γ through STAT1 after adoptive transfer into RAG -/- mice. Lymphopenic RAG -/- mice were injected i.v. with 6x1 6 of CTV-labeled T cells isolated from the LNs of congenic WT (n= 9) or STAT1 Tg (n= 9) mice. The levels of IL-7Ra, p-stat5 and p-stat1 of donor T cells were evaluated by flow cytometry in LNs 7 days post-transfer as function of CTV Fluorescence after in vitro stimulation with rmil-7 (1 ng/ml) and IFN-γ (1 ng/ml) respectively. (A) The percentages of donor T cells CTV + IL-7Ra high, CTV + IL-7Ra low, CTV - IL-7Ra high and CTV - IL-7Ra low are indicated. The MFIs of IL-7Ra in CD4 and CD8 donor T cells after adoptive

transfer into RAG -/- mice (SP and FP) were compared using a nonparametric Mann-Whitney test. (B) The percentages of donor T cells CTV + p-stat5 high, CTV + p-stat5 low, CTV - p-stat5 high and CTV - p-stat5 low are indicated. The MFIs of p-stat5 in CD4 and CD8 donor T cells before (d) and after adoptive transfer into RAG -/- mice (SP) were compared as described above. (C) The percentages of donor T cells CTV + p-stat1 high, CTV + p-stat1 low, CTV - p-stat1 high and CTV - p-stat1 low are indicated. The MFIs of p-stat1 in CD4 and CD8 donor T cells before (d) and after adoptive transfer into RAG -/- mice (SP) were compared as described above. Data are presented as box and whisker plots showing the median MFI value bounded by the first and third quartiles in the box, with whiskers extending to the minimum and maximum values from three independent experiments out of three, including an average of 3 mice per group and experiment. Supplemental References 1. Villarino A, et al. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. Elife. 216;5:e8384.

2 3 4 5 2 3 4 5 t 2 3 4 5 Figure S1 A B Lymph nodes Spleen Thymus C Lymph nodes Cell count (x1 6 ) 15 1 5 T WT ns ns ns g STAT1 Tg 3 2 1 8 8 8 T WT g STAT1 Tg 4 3 2 1 T WT g STAT1 Tg Cell count (x1 6 ) 4 3 2 1 ns CD4 T cells CD4 T cells ns CD8 T cells CD8 T cells WT STAT1 Tg D CD4 T cells CD8 T cells CD4 T cells CD8 T cells WT STAT1 Tg CD62L Tn Teff /em Tcm CD44 % T cell subsets 1 8 6 4 2 ns ns ns % Tn % Tcm % Tem-eff % Tn % Tcm % Tem-eff Tn Tcm Teff/ em ns ns ns Tn Tcm Teff/ em WT STAT1 Tg E WT STAT1 Tg CD4 T cells # Cells 12 9 6 3 IL-7Rα CD8 T cells 2 1 13 14 15 MFI IL-7Rα (x1 3 ) 2. 1.5 1..5 ns CD4 T cells CD4 T cells ns CD8 T cells CD8 T cells WT STAT1 Tg F CD4 T cells CD8 T cells MFI p-stat1 (x1 3 ) 15 1 5 g p<.1 T g T ns g p<.1 ns WT STAT1 Tg 3 stimulation: Unstim rmifn-α rmifn-γ Unstim rmifn-α rmifn-γ

Figure S2 A IL-7 Stimulation (9 ) WT CD4 Naïve T cells 124 58 128 STAT1 Tg WT CD8 Naïve T cells 144 478 82 STAT1 Tg IFN-γ Stimulation (9 ) WT 14 164 53 STAT1 Tg WT 1 13 64 STAT1 Tg B CD4 Naïve T cells CD8 Naïve T cells STAT1 Tg IL-7 stimulation IFN-γ stimulation IL-7 stimulation 571 65 113 488 72 68 IFN-γ stimulation

Figure S3 A IL-7 stimulation B WT STAT1 Tg WT IL-7 stimulation IL-7 stimulation overnight stimulation 46 2393 781 overnight stimulation 563 229 1549 8 2374 1465 STAT1 Tg IFN-γ stimulation IFN-γ stimulation C Log 2 (Fold change) Log 2 (Fold change) 6 4 2-2 -4-6 Overnight Stimulation with: 6 4 2-2 -4-6 Overnight Stimulation with: 7 Socs1 Bik Ifi27 Socs2 7 Bcl2 Cish Cxcl1 Ifit1 g g * * 7 7 g IL-7 IFN-γ IL-7 IFN-γ IL-7 IFN-γ IL-7 IFN-γ * * * * * * * g IL-7 IFN-γ IL-7 IFN-γ IL-7 IFN-γ IL-7 IFN-γ 7 7 g g 7 7 g g WT cells STAT1 Tg cells

Figure S4 A Z-score 4 2-2 IL-7 Stimulation (9 ) 4 2-2 Z-score B Cell Death and Survival IL-7 Stimulation (9 ) Cell Survival Cell Viability Cell Viability of Lymphocytes Cell Viability of T Lymphocytes Cell Viability of Leukocytes Z-score 1 2 3 4 5-4 -4 Z-score C WT Diseases or s Annotation #Mol generation of cells 134 proliferation of cells 221 development of blood cells 79 proliferation of epithelial cells 46 cell survival 95 development of leukocytes 77 proliferation of blood cells 89 activation of T lymphocytes 38 transactivation of RNA 48 proliferation of lymphocytes 82 IL-7 Stimulation (Overnight) STAT1 Tg Diseases or s Annotation #Mol generation of cells 133 formation of osteoclasts 15 cell viability of mononuclear leukocytes 28 development of blood cells 76 transactivation of RNA 46 cell survival 93 development of leukocytes 75 cell viability of lymphocytes 27 activation of cells 86 lymphatic node tumor 48 Cellular Growth and Proliferation Hematological System Development and Proliferation of Lymphocytes Proliferation of Mononuclear Leukocytes Proliferation of Immune Cells Cell Proliferation of T Lymphocytes Proliferation of Hematopoietic Cells Proliferation of B Lymphocytes Proliferation of Cells Proliferation of Blood Cells Generation of Cells Proliferation of Epithelial Cells Formation of Osteoclasts T cell Development T cell Homeostasis Quantity of Thymocytes Quantity of Regulatory T Lymphocytes Quantity of Bone Marrow Cells Development of Leukocytes Development of Lymphocytes Development of Blood Cells Development of Mononuclear Leukocytes Development of APCs Development of Bone Marrow 1 1 2 3 Z-score 2 3 4 4 5 5 1 5 11 55 WT STAT1 Tg Z-score -5-1 WT STAT1 Tg - -5 - -1 Z-score D IL-7 Stimulation (Overnight) -8-6 -4 Z-score -2 2 4 Diseases or s Annotation #Mol organismal death 495 morbidity or mortality 51 cell survival 321 cell viability 296 Diseases or s Annotation #Mol organismal death 55 morbidity or mortality 556 cell survival 357 cell viability 329 Cell Death and Survival Apoptosiss Cell Survival l Cell Viabilityy Cell Viability of Tumor Cell Liness Cell Viability of Blood Cellss Cell Viability of Leukocytes s cellular homeostasis 352 proliferation of cells 89 antibody response 44 cell movement 55 cell viability of tumor cell lines 22 survival of organism 183 Self-renewal of Cellss Cell Viability of Phagocytes s Cell Viability of T Lymphocytes s Cell Viability of Lymphocytes s survival of organism 169 migration of cells 458 cell viability of blood cells 74 cell movement 451 cellular homeostasis 377 proliferation of cells 891 WT STAT1 Tg

2 1 13 14 15 2 1 13 14 15 2 1 13 14 15 12 13 14 15 2 2 3 4 5 1 13 14 15 2 1 13 14 15 2 1 13 14 15 2 1 13 14 15 2 1 13 14 15 Figure S5 A Donor: CD4 donor T cells CD8 donor T cells <APC-A>: CD127 IL-7Rα <APC-A>: CD127 1 5 1 4 1 3 1 2 1 5 1 4 1 3 1 2 WT STAT1 Tg 5 23 21 6 32 54 5 9 <APC-A>: CD127 <APC-A>: CD127 1 5 1 4 1 3 1 2 1 5 1 4 1 3 1 2 42 31 21 6 27 6 8 5 CellTrace Violet MFI IL-7Rα (x1 3 ) 2. 1.5 1..5 CD4 donor T cells CD8 donor T cells p<.1 p<.1 ns p<.1 ns p<.1 ns P P SP FP SP FP P P T cells -> RAG -/- WT STAT1 Tg B Donor: CD4 donor T cells CD8 donor T cells p-stat5 WT STAT1 Tg 44 24 49 29 29 3 2 2 27 54 27 57 14 5 13 3 2 3 4 5 2 3 4 5 CellTrace Violet MFI p-stat5 (x1 3 ) 12 3 stimulation with rmil-7 8 4 CD4 donor T cells CD8 donor T cells d SP d SP - + - + - + - + ns - + - + - + - + - + - + - + - + - + - + - + - + ns T cells -> RAG -/- WT STAT1 Tg C CD4 donor T cells CD8 donor T cells Donor: CD4 donor T cells CD8 donor T cells p-stat1 <Alexa Fluor 488-A>: pstat1 1 5 1 4 1 3 1 2 5 1 63 33 WT 28 <Alexa Fluor 488-A>: pstat1 1 5 1 4 1 3 STAT1 Tg 1 31 2 4 26 3 CellTrace Violet 25 4 66 6 35 1 33 MFI p-stat1 (x1 3 ) 1 3 stimulation with rmifn-γ 8 6 4 2 d - + - + - + - + SP ns - + - + d - + - + SP - + - + - + - + - + - + - + - + ns T cells -> RAG -/- WT STAT1 Tg

Table S1. Overlapping DEGs by IL-7 and IFN-γ stimulation in WT T cells (Extented Table 2) IL-7 stimulation IFN-γ stimulation Gene ID Log 2 (FC) Adjusted p-value Log 2 (FC) Adjusted p-value CD4 Naive T cells 57358B9Rik 1.66 9.59E-15 1.19 4.51E-1 583468F6Rik 3.12 7.8E-24 3.9 4.E-24 933175E14Rik 2.16 1.18E-11 2.5 2.44E-13 95382P21Rik 1.56 1.35E-3 1.38 2.1E-2 Abcg3 1.19 6.93E-4 1.78 3.32E-6 Acvr1c 5.24 3.9E-16 2.77 9.28E-8 Arid5b 1.83 3.36E-6 2.48 1.28E-8 B4336N3Rik 1.42 1.82E-8 1.49 1.91E-8 Bcl3 2.41 5.19E-11 2.88 5.54E-13 Fas 1.11 1.34E-6 1.38 3.9E-8 Gadd45g 3.82 1.37E-9 2.67 1.62E-5 Gata1 2.5 1.48E-6 3.94 5.46E-11 Gbp1 2.92 1.37E-6 6.65 3.1E-16 Gbp11_1 6.5 1.62E-19 4.94 2.28E-16 Gbp4 2. 4.75E-9 4.22 4.81E-19 Gbp5 2.41 4.13E-11 4.82 4.24E-21 Gbp6_1 2.64 3.42E-5 5.48 2.24E-12 Gbp6_2 1.74 4.11E-4 5.16 3.9E-15 Gm12185 1.7 2.59E-1 3.92 2.24E-22 Gm16174 2.24 1.25E-3 2.1 1.64E-2 Gm26876 3.6 1.28E-9 1.55 1.77E-2 Gm4951 1.1 4.49E-2 3.81 1.37E-11 Gpr155 1.8 1.2E-4 1.41 3.16E-6 Gvin1 1.38 1.11E-3 3.11 3.27E-1 Ifi47 3.34 7.44E-11 4.79 1.69E-15 Igtp 2.64 2.3E-16 5.15 3.73E-27 Iigp1 2.68 1.89E-1 6.61 1.1E-23 Il12rb2 4.42 1.99E-6 2.51 2.71E-2 Il18rap 2.89 2.9E-11 2.61 8.2E-1 Il2rb 1.85 1.5E-14 1.43 4.81E-11 Irf4 2.25 2.76E-6 4.35 2.72E-13 Irf9 1.14 2.48E-11 2.53 4.12E-23 Irgm2 1.35 1.27E-8 4.33 4.57E-25 Jun 2.2 4.89E-1 2.34 1.99E-11

Kat2b 1.7 5.51E-17 1. 1.34E-9 Kit 2.2 8.39E-7 2.22 3.81E-7 Lrrtm2 2.96 8.47E-6 1.92 1.6E-2 Ly6a 1.32 2.53E-3 3.66 4.5E-12 Mgat4a 1.8 4.65E-8 1.52 1.49E-11 Ms4a6d 3.66 4.21E-14 1.32 2.12E-3 Nlrc5 1.49 1.15E-5 1.97 1.23E-7 Noc4l 1.8 4.91E-1 1.39 8.82E-13 Pim2 3.3 9.26E-29 2.99 1.52E-28 Pmepa1 1.85 9.31E-14 2.17 8.16E-16 Pole2 1.86 3.9E-16 1.18 8.64E-1 Ppa1 1.15 1.78E-4 1.85 6.6E-8 Rbpms 2.54 1.55E-7 1.48 5.98E-3 Rgs1 5.34 2.12E-15 1.33 3.98E-2 Ripk1 1.26 2.12E-15 1.44 3.2E-17 Samhd1 1.16 5.41E-7 1.93 2.41E-12 Slamf1 3.4 3.18E-2 1.85 9.77E-13 Socs1 2.47 2.93E-9 3.37 9.18E-13 Socs3 2.19 8.82E-23 1.6 5.3E-18 Tgtp1 4.27 1.11E-17 6.68 6.95E-25 Tgtp2 2.58 1.4E-16 5.37 1.79E-28 Tnfrsf1b 1.82 7.17E-17 1.8 1.6E-9 Tnfsf8 2.62 2.83E-14 1.39 2.E-6 Treml2 1.29 4.19E-13 1.38 8.29E-14 Zfp455 1.29 2.1E-5 1.13 7.16E-4 CD8 Naive T cells 583468F6Rik 2.27 1.66E-19 2.45 3.73E-2 933175E14Rik 1.94 9.44E-11 1.88 1.69E-9 95382P21Rik 1.96 2.75E-5 1.33 3.16E-2 Abcb11 1.63 2.49E-5 1.73 9.17E-5 B4336N3Rik 2.11 1.29E-13 1.13 1.36E-5 Bcl3 3.12 7.66E-15 3.33 5.29E-15 Csf1 2.42 3.64E-6 4.35 1.61E-11 Cyp2s1-1.25 9.56E-6 1.6 1.48E-3 F2rl2 2.3 5.14E-4 3.22 2.22E-6 Fas 1. 4.93E-6 1.19 1.73E-6 Gadd45g 5.15 1.7E-13 2.74 1.27E-5 Gata1 3.12 5.1E-9 4.38 2.86E-12 Gbp1 3.19 1.4E-7 6.16 5.29E-15 Gbp11_1 5.25 9.2E-18 4.71 1.63E-15 Gbp4 1.75 4.88E-8 3.53 4.42E-16 Gbp5 1.67 1.55E-7 3.67 1.51E-16 Gbp6_1 2.88 3.6E-6 5.24 1.1E-11

Gbp6_2 1.82 1.7E-4 4.25 3.9E-12 Gem 2.49 3.2E-6 2.6 1.36E-5 Gm12185 2.45 1.66E-15 3.68 4.72E-21 Gm16174 2.19 8.69E-4 2.5 1.5E-3 Gm26876 3.78 1.51E-1 1.86 2.54E-3 Gm47 1.52 8.6E-3 3.9 2.64E-6 Gm4951 1.27 4.65E-3 2.98 1.87E-8 Gpr155 1.38 5.96E-7 1.61 2.1E-7 Gpr83 3.88 1.27E-11 1.34 3.95E-2 Gvin1 1.95 2.89E-6 3.29 7.28E-11 Gzmb 3.1 4.27E-6 2.54 7.63E-4 Ifi47 3.61 3.8E-12 4.22 1.62E-13 Igtp 3.48 6.54E-21 5.14 8.5E-27 Iigp1 2.62 1.44E-1 6.19 3.57E-22 Il12rb2 3.37 1.6E-4 4.22 2.47E-5 Il18rap 1.82 6.75E-7 1.61 6.88E-5 Irf4 1.11 1.6E-2 2.91 4.18E-8 Irf9 1.25 6.63E-13 2.2 3.16E-19 Irgm1 1.75 6.21E-1 3.99 7.29E-21 Irgm2 1.95 2.3E-13 4.7 7.51E-24 Jun 3.65 2.39E-18 3.47 6.86E-17 Kit 1.71 9.58E-6 2.83 9.73E-1 Lgals3bp 1.13 1.86E-7 1.91 1.13E-12 Lrrtm2 1.75 5.53E-3 2.8 7.97E-3 Ly6a 1.93 4.98E-6 5.11 1.2E-16 Map3k8 4.32 6.1E-17 1.9 2.9E-2 Mthfd2 1.6 2.33E-8 1.57 3.6E-12 Muc1 1.18 4.77E-2 2.7 3.62E-5 Nlrc5 1.1 5.9E-4 1.4 1.86E-4 Noc4l 1.2 1.19E-9 1.13 6.4E-1 Parp14 1. 1.1E-4 1.88 1.72E-9 Pim2 3.38 1.2E-31 2.99 1.56E-28 Pole2 1.44 4.48E-13 1.1 7.82E-9 Ppa1 1.79 2.5E-8 2.3 7.96E-9 Rgs1 4.81 1.95E-14 1.35 3.74E-2 Ripk1 1. 9.67E-13 1.3 2.84E-12 Rnf157 1.1 1.29E-3 1.5 1.97E-2 Rtp4 1.52 4.59E-4 3.36 3.97E-1 Samhd1 1.1 7.32E-7 1.91 4.24E-12 Sema4a 1.22 7.31E-8 1.3 2.67E-5 Serpina3g 3.4 1.43E-6 4.75 5.86E-9 Slamf1 2.94 3.95E-2 1.72 1.21E-11 Socs3 1.99 1.17E-21 1.37 1.79E-15

Stat2 1.3 4.53E-6 1.71 2.43E-1 Syt6 4.5 8.62E-11 1.93 1.5E-2 Tgtp1 3.77 2.66E-16 5.38 3.5E-21 Tgtp2 2.59 3.55E-17 4.59 1.5E-25 Tnfsf8 2.27 8.19E-13 1.3 1.3E-5 Treml2 1.43 4.84E-15 1.16 2.26E-11 Lists of DEGs, their log 2 (FC) and adjusted p values generated for each condition were compared using Venn diagrams to obtain the list of overlapping genes between IL-7 and IFNγ stimulation in WT T cells. Fold changes (FC) were calculated relative to unstimulated condition for each sample.

Table S2. Top 15 IPA-predicted activated upstream regulators in WT T cells stimulated for 9 minutes with IFN-γ Upstream Regulator Activation Z-score p-value of overlap CD4 Naive T cells IFNG 8.25 1.13E-54 IRF7 6.14 1.55E-5 IFNA2 5.8 3.85E-4 TNF 5.743 6.58E-21 STAT1 5.646 6.36E-43 IL-1B 5.376 2.55E-21 IFNB1 5.161 1.49E-44 IL-21 5.134 6.24E-36 IRF3 5.61 7.82E-3 IRF1 4.499 8.41E-25 IL-6 4.45 2.89E-18 IFNL1 4.11 5.58E-22 OSM 4.88 1.14E-8 IRF5 3.923 8.5E-21 NFATC2 3.876 2.33E-22 CD8 Naive T cells IFNG 7.853 7.8E-52 IRF7 5.617 2.13E-45 IFNA2 5.371 4.5E-34 STAT1 5.271 1.7E-4 IFNB1 5.14 3.74E-39 IL-1B 5.41 5.14E-24 IRF3 4.675 3.72E-26 IL-21 4.64 9.34E-31 TNF 4.513 5.98E-17 IRF1 4.166 2.8E-22 IL-6 3.87 2.72E-2 OSM 3.715 3.11E-1 PRL 3.621 7.72E-19 NFATC2 3.615 2.4E-21 IRF5 3.53 3.99E-17

Lists of differentially expressed gene transcripts (DEGs). their log 2 (FC) and adjusted p values were generated for each condition and used as input in IPA software. Activation Z-score are based on a model that assigns random regulation directions for predicted upstream regulators. Z >2 predicts activation of the upstream regulator. The p-value of overlap was used to rank the significance associated for each Upstream Regulator. The p-value indicates the significance of the overlap between the genes targeted by the upstream regulator in the database and the experimental dataset.

Table S3. Target genes predicted by IPA with IFNG as activated upstream regulator in WT stimulated for 9 minutes with IL-7 or IFN-γ IL-7 stimulation IFN-γ stimulation Gene ID Log 2 (FC) Adjusted p- value Log 2 (FC) Adjusted p- value CD4 Naive T cells Bcl3 2.41 5.19E-11 2.88 5.54E-13 Fas 1.11 1.34E-6 1.38 3.9E-8 Gbp5 2.41 4.13E-11 4.82 4.24E-21 Gbp1 2.92 1.37E-6 6.65 3.1E-16 Gvin1 1.38 1.11E-3 3.11 3.27E-1 Ifi47 3.34 7.44E-11 4.79 1.69E-15 Igtp 2.64 2.3E-16 5.15 3.73E-27 Iigp1 2.68 1.89E-1 6.61 1.1E-23 Il12rb2 4.42 1.99E-6 2.51 2.71E-2 Il18rap 2.89 2.9E-11 2.61 8.2E-1 Irf4 2.25 2.76E-6 4.35 2.72E-13 Irf9 1.14 2.48E-11 2.53 4.12E-23 Irgm2 1.35 1.27E-8 4.33 4.57E-25 Jun 2.2 4.89E-1 2.34 1.99E-11 Ly6a 1.32 2.53E-3 3.66 4.5E-12 Nlrc5 1.49 1.15E-5 1.97 1.23E-7 Pim2 3.3 9.26E-29 2.99 1.52E-28 Ripk1 1.26 2.12E-15 1.44 3.2E-17 Samhd1 1.16 5.41E-7 1.93 2.41E-12 Slamf1 3.4 3.18E-2 1.85 9.77E-13 Socs1 2.47 2.93E-9 3.37 9.18E-13 Socs3 2.19 8.82E-23 1.6 5.3E-18 Tgtp1 4.27 1.11E-17 6.68 6.95E-25 Tnfrsf1b 1.82 7.17E-17 1.8 1.6E-9 CD8 Naive T cells Bcl3 3.12 7.66E-15 3.33 5.29E-15 Csf1 2.42 3.64E-6 4.35 1.61E-11 Fas 1. 4.93E-6 1.19 1.73E-6 Gbp5 1.67 1.55E-7 3.67 1.51E-16 Gbp1 3.19 1.4E-7 6.16 5.29E-15 Gpr83 3.88 1.27E-11 1.34 3.95E-2 Gvin1 1.95 2.89E-6 3.29 7.28E-11 Ifi47 3.61 3.8E-12 4.22 1.62E-13

Igtp 3.48 6.54E-21 5.14 8.5E-27 Iigp1 2.62 1.44E-1 6.19 3.57E-22 Il12rb2 3.37 1.6E-4 4.22 2.47E-5 Il18rap 1.82 6.75E-7 1.61 6.88E-5 Irf4 1.11 1.6E-2 2.91 4.18E-8 Irf9 1.25 6.63E-13 2.2 3.16E-19 Irgm2 1.95 2.3E-13 4.7 7.51E-24 Irgm1 1.76 6.21E-1 4. 7.29E-21 Jun 3.65 2.39E-18 3.47 6.86E-17 Lgals3bp 1.13 1.86E-7 1.91 1.13E-12 Ly6a 1.93 4.98E-6 5.11 1.2E-16 Map3k8 4.32 6.1E-17 1.9 2.9E-2 Nlrc5 1.1 5.9E-4 1.4 1.86E-4 Pim2 3.38 1.2E-31 2.99 1.56E-28 Ripk1 1. 9.67E-13 1.3 2.84E-12 Rtp4 1.52 4.59E-4 3.36 3.97E-1 Samhd1 1.1 7.32E-7 1.91 4.24E-12 Sema4a 1.22 7.31E-8 1.3 2.67E-5 Serpina3g 3.4 1.43E-6 4.75 5.86E-9 Slamf1 2.94 3.95E-2 1.72 1.21E-11 Socs3 1.99 1.17E-21 1.37 1.79E-15 Stat2 1.3 4.53E-6 1.72 2.43E-1 Tgtp1 3.77 2.66E-16 5.38 3.5E-21 Lists of DEGs, their log 2 (FC) and adjusted p-values generated for each condition were used as input in IPA software to obtain a list of predicted upstream regulators (Figure 4A and Table S2) and their target genes among the DEGs. Fold changes (FC) were calculated relative to unstimulated condition for each sample.

Table S4. Target genes predicted by IPA with STAT1 as activated upstream regulator in WT T cells stimulated for 9 minutes with IL-7 or IFN-γ IL-7 stimulation IFN-γ stimulation Gene ID Log 2 (FC) Adjusted p- value Log 2 (FC) Adjusted p- value CD4 Naive T cells Fas 1.11 1.34E-6 1.38 3.9E-8 Gbp5 2.41 4.13E-11 4.82 4.24E-21 Gbp1 2.92 1.37E-6 6.65 3.1E-16 Ifi47 3.34 7.44E-11 4.79 1.69E-15 Igtp 2.64 2.3E-16 5.15 3.73E-27 Il12rb2 4.42 1.99E-6 2.51 2.71E-2 Irf9 1.14 2.48E-11 2.53 4.12E-23 Jun 2.2 4.89E-1 2.34 1.99E-11 Samhd1 1.16 5.41E-7 1.93 2.41E-12 Socs1 2.47 2.93E-9 3.37 9.18E-13 Socs3 2.19 8.82E-23 1.6 5.3E-18 Tgtp1 4.27 1.11E-17 6.68 6.95E-25 CD8 Naive T cells Fas 1. 4.93E-6 1.19 1.73E-6 Gbp5 1.67 1.55E-7 3.67 1.51E-16 Gbp1 3.19 1.4E-7 6.16 5.29E-15 Gzmb 3.1 4.27E-6 2.54 7.63E-4 Ifi47 3.61 3.8E-12 4.22 1.62E-13 Igtp 3.48 6.54E-21 5.14 8.5E-27 Il12rb2 3.37 1.6E-4 4.22 2.47E-5 Irf9 1.25 6.63E-13 2.2 3.16E-19 Irgm1 1.76 6.21E-1 4. 7.29E-21 Jun 3.65 2.39E-18 3.47 6.86E-17 Samhd1 1.1 7.32E-7 1.91 4.24E-12 Serpina3g 3.4 1.43E-6 4.75 5.86E-9 Socs3 1.99 1.17E-21 1.37 1.79E-15 Stat2 1.3 4.53E-6 1.72 2.43E-1 Tgtp1 3.77 2.66E-16 5.38 3.5E-21 Lists of DEGs, their log 2 (FC) and adjusted p-values generated for each condition were used as input in IPA software to obtain a list of predicted upstream regulators (Figure 4A and

Table S2) and their target genes among the DEGs. Fold changes (FC) were calculated relative to unstimulated condition for each sample.

Table S5. Top 15 IPA-predicted activated upstream regulators in STAT1 Tg T cells stimulated for 9 minutes with IL-7 Upstream Regulator Activation Z-score p-value of overlap CD4 Naive T cells IL-2 4.22 7.93E-32 IRF7 4.11 7.54E-8 IFNG 4.8 2.36E-27 IL-4 3.92 4.6E-34 IL-5 3.638 1.7E-2 CSF2 3.551 3.5E-18 STAT1 3.481 1.37E-14 IL-15 3.388 2.38E-17 EPO 3.377 2.24E-8 STAT5B 3.363 1.87E-13 IL-18 3.298 2.3E-7 STAT4 3.292 1.14E-14 IL-7 3.226 8.91E-21 IL-3 3.221 1.91E-13 IFNA2 2.99 1.21E-1 CD8 Naive T cells IFNG 5.577 1.58E-29 IL-2 5.368 1.62E-34 STAT1 5.42 5.64E-18 IRF7 4.62 5.34E-13 IL-1B 4.327 4.42E-19 STAT4 4.149 3.35E-16 IL-5 4.41 3.63E-19 IL-3 4.29 1.29E-13 PRL 3.925 1.28E-14 IL-15 3.867 1.9E-19 IFNA2 3.89 2.22E-14 IL-13 3.73 1.75E-5 IL-18 3.7 4.95E-9 IL-7 3.622 9.8E-25 IL-21 3.587 3.35E-18

Lists of differentially expressed gene transcripts (DEGs). their log 2 (FC) and adjusted p values were generated for each condition and used as input in IPA software. Activation Z-score are based on a model that assigns random regulation directions for predicted upstream regulators. Z >2 predicts activation of the upstream regulator. The p-value of overlap was used to rank the significance associated for each Upstream Regulator. The p-value indicates the significance of the overlap between the genes targeted by the upstream regulator in the database and the experimental dataset.

Table S6. Top 1 DAVID-predicted enriched Biological processes within DEGs unique to CD4 or CD8 Naive T cells stimulated for 9 minutes with IL-7 WT cells stimulated with IL-7 STAT1 Tg cells stimulated with IL-7 CD4 Naive T cells Description Gene counts p-value Description Gene counts p-value Regulation of programmed cell death 16 1.46E-4 Regulation of programmed cell death 14 5.82E-3 Regulation of cell death 16 1.55E-4 Regulation of cell death 14 6.8E-3 Death 15 2.29E-4 Death 16 3.45E-4 Regulation of apoptosis 15 4.35E-4 Regulation of apoptosis 14 5.25E-3 Apoptosis 14 2.75E-4 Apoptosis 15 3.64E-4 Programmed cell death 14 3.24E-4 Programmed cell death 15 4.32E-4 Cell death 14 6.24E-4 Cell death 15 8.55E-4 Positive regulation of macromolecule metabolic process 12 2.7E-2 Phosphate metabolic process 17 1.87E-2 Intracellular signaling cascade 16 1.7E-2 Phosphorus metabolic process 17 1.87E-2 Regulation of cell proliferation 11 2.29E-2 Cell cycle 14 1.16E-2 CD8 Naive T cells Hemopoietic or lymphoid organ development 8 1.84E-2 Hemopoietic or lymphoid organ development 7 1.83E-2 Immune system development 8 2.33E-2 Immune system development 7 2.27E-2

Immune response 14 5.76E-4 Homeostatic process 11 1.15E-2 Regulation of small GTPase mediated signal transduction 7 2.23E-2 Regulation of hydrolase activity 6 1.54E-2 Regulation of Ras protein signal transduction 6 3.E-2 Hemopoiesis 6 3.92E-2 Gland development 6 4.8E-2 Small GTPase mediated signal transduction 6 4.33E-2 Tissue homeostasis 5 1.31E-3 Regulation of GTPase activity 5 5.6E-3 Multicellular organismal homeostasis 5 4.74E-3 Homeostasis of number of cells 5 9.98E-3 Anatomical structure homeostasis 5 8.21E-3 Regulation of cytokine production 5 2.E-2 Lymph node development 4 7.41E-4 Regulation of cytokine secretion 4 1.7E-4 Gene Ontology (GO) term enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 6.7 (https://david.ncifcrf.gov/) to assess the top biological processes associated with the lists of DEGs by IL-7 in WT and STAT1 Tg T cells. Lists of DEGs. their log 2 (FC) and adjusted p values generated for WT and STAT1 Tg T cells stimulated for 9 minutes with rmil-7 were used as input in DAVID website. Gene counts indicate the number of enriched DEGs in the pathway. The p-value indicates the perturbation of each pathway.

Table S7. Overlapping DEGs by IL-7 and IFN-γ overnight stimulation in WT and STAT1 Tg CD4 Naïve T cells WT cells stimulated with IL-7 STAT1 Tg cells stimulated with IL-7 WT cells stimulated with IFN-γ Gene ID CD4 Naive T cells Log 2 (FC) Adjusted p-value Log 2 (FC) Adjusted p-value Log 2 (FC) Adjusted p-value 619L18Rik 1.44 1.16E-4 1.49 2.26E-4 1.28 2.61E-4 6138B21Rik 1.25 1.94E-3 1.16 6.74E-3 1.2 2.45E-3 1112L1Rik 1.77 1.36E-6 2.18 6.73E-7 2.16 1.81E-7 11132F4Rik -1.69 2.9E-7-1.82 4.53E-7-1.3 2.4E-6 1197I7Rik 1.13 3.94E-4 1.61 5.96E-5 1.37 7.55E-5 132E11Rik 1.21 2.44E-7 1.33 3.13E-7 1.53 2.38E-8 171K19Rik -1.25 2.15E-2-1.71 6.99E-3-1.86 1.69E-3 171I14Rik 1.24 3.34E-4 1.7 2.23E-3 1.55 4.67E-5 1719B3Rik -2.97 7.71E-4-4.3 1.8E-4-4.67 1.71E-5 1721A7Rik 1.55 3.66E-3 1.29 2.15E-2 1.68 1.99E-3 1725G4Rik 1.4 2.82E-9 1.58 3.71E-9 1.5 6.6E-9 1729H14Rik -1.52 2.15E-3-2.4 5.97E-4-2. 2.54E-4 173C12Rik -1.76 3.22E-2-1.79 4.91E-2-2.22 8.39E-3 173J22Rik -1.31 1.32E-2-1.21 3.52E-2-1.19 2.3E-2 173K9Rik 1.84 4.6E-6 1.45 9.19E-5 2.23 6.73E-7 1752N19Rik 1.61 7.81E-1 1.76 1.11E-9 1.89 5.E-11 1766B19Rik 2.2 2.4E-3 1.84 1.45E-2 2.69 4.98E-4 1767K1Rik 1.66 4.76E-3 1.72 7.78E-3 1.88 1.87E-3 1819A15Rik 1.98 6.88E-3 1.64 3.48E-2 2.21 3.6E-3 18114B1Rik 1.33 4.55E-6 1.32 1.34E-5 1.74 3.56E-7 18134E14Rik 2.5 2.9E-4 2.34 1.85E-4 3.2 6.78E-6 18141H14Rik -1.66 3.64E-4-2.34 6.6E-5-1.8 1.72E-4 18149J17Rik -1.22 3.81E-3-1.31 5.14E-3-1.33 1.96E-3 18155G2Rik -1.46 6.57E-7-1.73 4.45E-7-2.48 7.7E-9 18162O18Rik 1.29 1.15E-3 1.59 5.56E-4 1.18 1.95E-3 2116I18Rik 2.38 1.52E-8 2.61 2.7E-8 2.95 1.48E-9 213C2Rik -1.1 3.25E-2-1.4 1.3E-2-1.25 9.83E-3 21315B3Rik 1.58 1.52E-6 1.6 3.71E-6 2.11 9.88E-8

2312F9Rik 2.87 8.25E-4 2.5 1.54E-2 2.89 7.4E-4 2319A5Rik 1.39 2.41E-5 1.36 7.44E-5 1.79 2.18E-6 23126I22Rik -1.83 2.49E-2-2.19 1.79E-2-2.44 4.45E-3 23131A7Rik -1.61 8.93E-4-2.35 1.12E-4-1.1 9.88E-3 23133P9Rik -1.14 6.86E-9-1.4 5.61E-9-1.31 1.E-9 2417B7Rik 1.49 5.36E-4 1.9 2.3E-4 1.74 1.39E-4 254C2Rik 1.16 4.53E-4 1.23 6.61E-4 1.53 4.1E-5 2519E7Rik.6 8.43E-4 1.9 1.75E-5 1.4 7.93E-6 2615L7Rik -1.7 4.43E-6-1.42 1.18E-6-1. 6.43E-6 26115P9Rik.81 1.39E-4 1.7 3.63E-5 1.31 1.97E-6 26135D17Rik 1.32 7.6E-5 1.36 1.49E-4 1.93 2.34E-6 261318N2Rik -1.8 1.3E-3-1.55 1.55E-4-1.71 2.19E-5 26157I1Rik 1.36 8.43E-7 1.3 3.38E-6 1.52 2.37E-7 2768H2Rik 1.73 1.71E-2 2.33 5.79E-3 1.47 3.59E-2 2781O15Rik -.92 9.31E-4-1.25 2.1E-4-1.23 8.8E-5 2799C18Rik -2.29 1.11E-5-2.76 6.28E-6-2.12 1.78E-5 2812D19Rik 1.5 2.74E-5 1.69 2.58E-5 1.68 8.35E-6 2816K23Rik 1.13 5.53E-5 1.73 4.E-6 1.65 1.72E-6 28139B14Rik 1.68 1.26E-5 1.44 1.16E-4 1.51 2.54E-5 28141L24Rik 2.3 1.1E-4 2.5 2.32E-4 1.85 1.87E-4 281414N6Rik 2.18 1.47E-4 2.72 6.1E-5 2.42 5.27E-5 281429I4Rik -2.3 1.45E-3-2.67 4.45E-4-2.97 6.7E-5 295J15Rik 1.78 5.69E-6 1.63 3.15E-5 1.65 8.55E-6 2979G21Rik -1.93 1.12E-2-1.91 2.16E-2-2.73 1.5E-3 3111I22Rik -2.92 1.6E-3-2.76 5.1E-3-2.7 2.55E-3 3117F17Rik 1.58 3.12E-4 1.6 1.6E-2 1.64 2.1E-4 3119E18Rik 1.83 1.2E-4 1.6 7.4E-4 2.7 3.18E-5 31143O21Rik -2.31 5.23E-7-2.9 2.39E-7-2.93 5.9E-8 31152M2Rik 1.23 9.6E-7 1.23 2.48E-6 1.45 1.63E-7 31162M4Rik 1.48 4.89E-6 2.3 9.96E-7 2.4 2.48E-7 3632454L22Rik 2.43 3.36E-6 2.32 1.34E-5 3.21 2.33E-7 38346C13Rik.62 1.59E-4 1.2 6.3E-6 1.14 7.4E-7 38348C21Rik 1.84 7.13E-4 1.8 1.93E-3 2.67 3.6E-5 463244H12Rik 1.21 1.96E-7 1.59 7.53E-8 1.31 6.68E-8 483144E17Rik 1.46 5.72E-4 1.21 4.82E-3 1.96 4.56E-5 4833422C13Rik 1.25 2.76E-5 1.1 2.7E-4 2.77 2.67E-8 493412L5Rik -1.59 8.53E-3-2.9 3.13E-3-1.53 9.88E-3 493422M22Rik 2.4 2.82E-3 2.77 7.18E-4 2.31 1.7E-3

493427A7Rik -2.2 6.E-5-2.43 3.43E-5-1.98 5.95E-5 49343F8Rik 1.77 2.16E-6 1.51 2.23E-5 2.1 3.79E-7 493453N24Rik 1.56 2.26E-9 1.74 3.36E-9 1.59 5.16E-1 493458D5Rik -1.41 3.24E-2-2.28 4.12E-3-1.49 2.33E-2 493469K13Rik 1.78 1.92E-3 1.64 7.3E-3 1.92 1.2E-3 493473A2Rik.6 3.18E-2 1.26 6.33E-4 1.4 1.2E-3 493486L24Rik -1.54 3.82E-3-1.79 3.E-3-1.35 7.87E-3 49352E9Rik 1.63 4.14E-2 2.35 1.14E-2 2.3 6.14E-3 49359E16Rik 2.95 9.74E-4 2.16 1.53E-2 2.74 1.52E-3 493512H18Rik 1.64 2.72E-3 2.34 4.6E-4 2.75 4.38E-5 493516B21Rik 3.38 1.27E-5 2.6 1.6E-3 3.61 5.9E-6 493526L6Rik 1.44 2.42E-2 2.35 2.56E-3 2.1 2.3E-3 493539E8Rik 1.41 1.53E-3 1.35 4.46E-3 1.45 1.11E-3 493579G24Rik -1.21 4.91E-5-1.44 2.9E-5-1.25 2.98E-5 493581F22Rik 1.89 4.46E-8 1.93 9.43E-8 1.96 1.75E-8 493594M22Rik 2.24 2.9E-3 1.8 2.1E-2 1.71 1.37E-2 493146C7Rik.9 3.64E-5 1.33 3.8E-6 1.14 3.98E-6 4931414P19Rik.94 2.56E-4 1.67 5.58E-6 1.81 7.74E-7 493344O12Rik 1.9 4.36E-8 2.12 5.25E-8 1.88 2.51E-8 493348B17Rik 2.74 7.46E-5 2.78 1.68E-4 3.37 1.1E-5 493348J17Rik -2.28 7.45E-3-1.95 3.2E-2-2.76 1.92E-3 4933427D14Rik 1.6 1.15E-7 1.4 4.51E-8 1.32 1.29E-8 4933439C1Rik 1.2 1.65E-3.99 1.21E-2 1. 5.14E-3 4933439K11Rik 1.83 1.6E-2 1.97 1.95E-2 1.89 1.23E-2 533426P16Rik 1.4 9.67E-8 1.6 9.78E-8 1.54 2.75E-8 54343G16Rik 1.48 1.83E-7 1.31 1.28E-6 1.71 3.66E-8 54345H2Rik -1.1 1.8E-7-1.6 3.44E-7-1.11 5.71E-8 57358B9Rik -1.25 3.14E-6-1.3 6.19E-6-1.24 2.77E-6 583428H23Rik 1.59 2.51E-8 1.69 4.35E-8 1.83 4.45E-9 583468F6Rik 2.7 8.78E-5 3.21 5.46E-5 2.46 1.65E-4 63443J6Rik 1.9 8.62E-6 1.44 2.21E-4 2.17 2.13E-6 63458C11Rik 1.18 4.5E-7 1.29 5.95E-7 1.29 1.52E-7 633418K2Rik.72 4.93E-3 1.18 3.19E-4 1.22 8.7E-5 633419J24Rik -2.38 2.63E-3-3.4 4.62E-4-3.23 2.46E-4 633549D23Rik 1.31 1.34E-2 1.47 1.31E-2 1.68 2.61E-3 643571L13Rik -1.62 1.41E-3-1.51 5.1E-3-2.4 2.2E-4 65349C15Rik 1.16 1.51E-5 1.25 2.24E-5 1.49 1.47E-6 923114K14Rik -2.41 5.58E-7-2.66 6.82E-7-2.89 8.68E-8

933151L19Rik 1.18 1.15E-6 1.31 1.38E-6 1.6 2.16E-6 933161L9Rik -2.33 1.18E-5-1.7 4.6E-4-1.67 1.66E-4 933175E14Rik 1.55 3.35E-9 1.74 4.39E-9 2.76 3.59E-11 94338I1Rik -.86 2.82E-4-1.34 2.1E-5-1.42 3.78E-6 983147E19Rik 2.23 1.23E-4 1.71 2.19E-3 1.76 7.23E-4 A2356P14Rik 4.21 5.96E-5 4.55 8.16E-5 3.29 3.79E-4 A3317A19Rik 1.36 9.72E-3 1.85 2.93E-3 1.43 6.7E-3 A4346D13Rik 1.42 1.92E-7 1.66 1.59E-7 2.1 8.56E-9 A4315I19Rik 1.74 2.51E-5 2.44 4.E-6 2.3 1.86E-6 A5372M11Rik 1.1 9.93E-4 1.38 2.2E-4 1.78 8.32E-6 A5383I2Rik 1.39 1.62E-6 1.19 1.61E-5 2.15 3.8E-8 A6323P12Rik 1.1 1.16E-6.98 4.15E-6 1.71 1.22E-8 A935H1Rik 1.9 4.67E-7 1.19 6.19E-7 1.39 4.27E-8 A937I19Rik -1.51 1.78E-5-1.31 1.53E-4-1.16 1.4E-4 A9324E5Rik -2.64 2.86E-6-2.64 7.97E-6-2. 2.52E-5 Aaed1 1.2 1.33E-7 1.4 1.1E-6 1.57 9.97E-9 Aar2 -.94 1.43E-7-1.2 1.99E-7-1.13 2.17E-8 Aars -1.8 1.81E-7-1.7 5.14E-7-1.16 6.38E-8 Aasdh.71 1.82E-6 1. 3.2E-7 1.1 3.45E-8 Abca1-2.29 3.4E-5-2.99 8.63E-6-2.57 9.43E-6 Abca5-1.47 3.89E-4-1.4 1.33E-3-1.42 4.49E-4 Abcb11 3.8 1.14E-6 3.8 5.66E-7 2.81 1.93E-6 Abcb1a -2.33 1.48E-6-2.75 1.7E-6-2.57 4.8E-7 Abcb1b -1.54 1.53E-6-1.46 6.69E-6-1.8 3.13E-7 Abcb4-1.89 1.69E-4-1.35 4.55E-3-1.71 3.33E-4 Abcb9-1.9 2.16E-6-2.1 3.68E-6-2.42 2.5E-7 Abcd4 1.8 5.66E-7 1.11 1.19E-6 1.2 1.57E-7 Abcg1-1.71 2.E-8-2.2 1.75E-8-2.23 1.44E-9 Abcg4 1.55 5.55E-3 2.46 4.97E-4 1.85 1.55E-3 Abhd14a 1.79 4.85E-7 1.75 1.59E-6 1.14 1.7E-5 Abhd14b 1.32 8.19E-7 1.5 7.77E-7 1.52 1.8E-7 Abi2-1.25 3.8E-7-1.23 1.16E-6-1.23 2.88E-7 Abl2-1.16 5.68E-8-1.25 9.1E-8-1.43 7.19E-9 Acaa1a 1.5 7.8E-8 1.17 8.59E-8 1.23 1.22E-8 Acacb -2.8 4.37E-4-1.83 2.58E-3-2.85 2.88E-5 Acad12 1.35 7.72E-5.83 6.58E-3 1.61 1.46E-5 Acadsb 2.1 2.4E-5 2.51 1.1E-5 1.82 4.65E-5 Acbd5-1.41 3.91E-7-1.48 7.8E-7-1.5 1.66E-7

Acer2-1.39 8.67E-8-1.52 1.2E-7-2.1 2.5E-9 Acot13 1.24 1.24E-6 1.37 1.48E-6 1.41 3.12E-7 Acot2-1.62 1.96E-7-1.98 1.18E-7-1.77 6.28E-8 Acot7-1.19 6.88E-3-1.1 2.4E-2-2.4 3.6E-5 Acox1-1.18 3.19E-8-1.33 3.89E-8-1.45 3.65E-9 Acp5 1.26 1.32E-8 1.24 3.52E-8 1.41 2.65E-9 Acrbp 1.28 5.77E-6 1.69 1.6E-6 1.72 3.7E-7 Acsl1 -.92 8.54E-8-1.1 6.55E-8-1.44 1.98E-9 Acsl3-1.7 1.81E-7-1.81 2.9E-7-2.26 1.25E-8 Acsm3 1.93 1.47E-2 2.67 4.11E-3 2.49 2.82E-3 Acss1 1.9 2.79E-8.91 2.49E-7 1.55 1.25E-9 Actb 1.55 8.72E-9 1.59 1.82E-8 1.25 1.61E-8 Actrt3-2.77 9.42E-4-3.25 6.63E-4-2.4 6.78E-3 Acvr2a -1.22 3.64E-7-1.19 1.26E-6-1.76 1.39E-8 Acvr2b 1.47 3.21E-3 1.7 2.51E-3 1.14 1.38E-2 Acyp1 1.8 5.87E-7 1.17 8.24E-7 1.49 2.91E-8 Adam22 1.72 3.72E-7 2.25 1.28E-7 2.4 6.22E-8 Adam8 1.55 2.73E-3 1.9 1.46E-3 1.68 1.44E-3 Adamts14-1.93 1.22E-5-2.37 5.83E-6-2.45 1.23E-6 Adamts3-2.6 7.64E-4-2.81 1.1E-3-3.46 6.99E-5 Adamtsl4 4.42 9.89E-9 4.92 1.27E-8 2.45 4.1E-7 Adap1-1.6 1.76E-2-1.77 1.9E-2-1.53 2.7E-2 Adat1 1.6 5.62E-8 2.6 2.83E-8 2.9 4.4E-9 Adcy5 1.8 6.79E-3 1.95 2.27E-4 1.19 3.33E-3 Adcy6 1.21 1.44E-8 1.25 2.89E-8 1.42 2.3E-9 Add1 1.14 3.79E-11 1.1 1.97E-1 1.41 1.81E-12 Adgrg1-1.81 3.1E-2-1.98 3.38E-2-3.15 9.7E-4 Adgrg3-1.63 4.82E-4-1.85 4.39E-4-3.59 5.3E-7 Adgrg5-1.28 5.56E-4-1.41 6.43E-4-1.88 2.11E-5 Adgrl2-3.2 2.69E-5-4.32 5.9E-6-5.32 2.72E-7 Adprh 1.4 1.72E-6 1.11 2.76E-6 1.15 5.77E-7 Aebp2-1.14 5.78E-8-1.3 6.39E-8-1.34 9.74E-9 Aff1-2.34 7.74E-8-2.79 6.7E-8-2.72 1.42E-8 Aff4-1.59 3.89E-8-1.75 5.3E-8-1.69 1.26E-8 Ager 2.32 6.13E-9 2.48 1.1E-8 2.72 7.86E-1 Agfg2 1.13 5.5E-8 1.13 1.3E-7 1.12 3.8E-8 Aggf1 -.99 2.56E-7-1.11 2.77E-7-1.2 1.33E-7 Agpat9-3.1 8.8E-5-4.35 1.4E-5-5.9 1.4E-6

Agrp 2.8 4.36E-3 1.65 3.9E-2 2.88 3.72E-4 Ahnak -1.79 1.34E-6-2.12 9.1E-7-2.6 3.2E-7 AI46766 1.4 1.67E-9 1.44 3.54E-9 1.85 7.74E-11 AI54432 1.57 1.52E-4 1.41 8.44E-4 1.54 1.57E-4 Aida.93 1.51E-7 1.5 1.53E-7 2.6 3.39E-1 Aig1-1.59 6.11E-7-2.2 2.48E-7-1.53 6.23E-7 Aim1-1.19 8.54E-8-1.24 1.65E-7-2.32 4.67E-1 Aim1l -1.14 1.35E-2-1.81 1.4E-3-1.21 8.72E-3 Airn 1.57 2.28E-6 1.59 5.68E-6 1.49 2.81E-6 Ak6-1.4 5.64E-7 -.99 2.44E-6-1.17 1.53E-7 Akap2-1.33 1.19E-5-1.6 7.15E-6-1.92 4.6E-7 Akr1e1 1.35 2.46E-6 1.47 3.48E-6 1.9 1.24E-5 Akr7a5 1.1 2.17E-5 1.3 9.87E-5 1.6 2.54E-5 Aldh1l2 2.4 4.E-5 1.69 4.66E-4 2.69 3.5E-6 Alg6 1.5 3.65E-5 1.31 1.51E-5 1.3 4.82E-6 Alkbh2 1.16 4.62E-6 1.34 3.88E-6 1.38 8.15E-7 Als2cr12 1.64 6.31E-4 2.4 2.84E-4 1.56 8.32E-4 Amd1-1.93 8.93E-7-2.44 3.75E-7-2.65 4.56E-8 Amd2-2.45 2.2E-5-1.91 4.21E-4-2.1 9.72E-5 Amdhd2.95 3.27E-5 1.4 4.2E-5 1.15 5.11E-6 Amigo1 1.9 1.7E-6 1.71 7.16E-6 1.5 6.41E-6 Amn1 1.28 1.46E-6 1.53 9.15E-7 1.75 7.93E-8 Ampd1-1.2 1.49E-5-1.31 1.95E-5-1.84 3.3E-7 Amt 2.5 3.33E-8 1.96 1.7E-7 2.13 1.26E-8 Amy1 1.42 1.4E-4 1.43 2.55E-4 1.94 6.38E-6 Anapc7-1.4 1.1E-8-1.9 1.75E-8-1.13 2.26E-9 Angptl6 2.17 7.16E-6 2.3 1.22E-5 2.1 7.89E-6 Ankrd13c -1.39 2.55E-7-1.52 3.41E-7-1.41 1.56E-7 Ankrd13d 1.24 8.43E-7 1.2 2.93E-6 1.49 1.29E-7 Ankrd5-2.24 3.3E-7-2.71 1.82E-7-2.89 2.58E-8 Ankrd53 1.94 8.27E-4 1.63 5.88E-3 2.36 1.59E-4 Ankzf1.98 1.3E-7 1.2 1.9E-7 1.35 5.37E-9 Anln -1.7 2.13E-2-1.53 5.3E-3-2.8 2.21E-4 Anxa4 1.82 1.8E-5 2.8 1.6E-5 1.41 1.34E-4 Anxa7 1.1 1.13E-7 1.25 6.8E-8 1.28 1.13E-8 Ap1m2 -.82 3.4E-4-1.42 1.1E-5-1.17 1.53E-5 Ap1s3-1.4 4.68E-6 -.97 2.34E-5-1.8 2.85E-6 Ap3s2.98 2.36E-8 1.13 2.37E-8 1.14 3.78E-9

Ap5b1 1.31 5.63E-7 1.12 5.7E-6 1.66 5.39E-8 Apbb1 1.71 2.3E-5 1.68 6.23E-5 1.52 4.65E-5 Apcdd1-2.17 1.58E-2-2.28 2.23E-2-3.66 4.46E-4 Apex1-1.43 7.69E-8-1.64 7.76E-8-2.42 1.4E-9 Aph1b -1.14 1.98E-2-1.18 2.91E-2-1.68 1.62E-3 Aplf 1.14 5.26E-6 1.4 2.61E-6 1.32 1.2E-6 Apmap -1.7 2.8E-8-1.22 2.94E-8-1.18 6.96E-9 Apobec2 1.42 1.18E-3 1.85 3.89E-4 1.99 7.27E-5 Apobec3 1.7 5.3E-7 1.16 7.27E-7 2.15 1.83E-9 Apol8-3.22 8.42E-5-3.47 1.17E-4-4.47 4.32E-6 Apol9a -2.98 1.68E-3-3.64 9.5E-4-3.6 1.25E-3 Apol9b -3.5 3.8E-5-3.54 2.37E-5-2.66 8.48E-5 Appbp2-1.4 1.47E-7-1.8 2.97E-7-1.2 2.96E-8 Arc -1.36 5.13E-5-1.49 6.36E-5-2.3 1.38E-6 Areg -3.8 4.63E-6-1.96 4.97E-4-3.2 4.47E-6 Arf4-1.61 1.19E-7-1.83 1.24E-7-2. 1.36E-8 Arhgap12 1.78 2.12E-9 1.87 3.71E-9 1.3 4.52E-9 Arhgap17-1. 4.43E-8-1.14 4.63E-8-1.23 5.36E-9 Arhgap2-2.83 4.52E-4-1.97 1.13E-2-2.48 1.1E-3 Arhgef1-2.7 5.13E-6-3.72 9.94E-7-1.66 2.57E-4 Arhgef5-1.12 4.38E-4-1.2 6.7E-4-1.23 1.88E-4 Arid4b -1.8 9.57E-8-1.5 3.2E-7-1.9 5.26E-8 Arid5a -1.28 4.9E-8-1.45 4.55E-8-1.55 5.25E-9 Arih1-1. 2.79E-8-1.5 5.1E-8-1.8 8.17E-9 Arih2-1.23 1.1E-8-1.33 1.55E-8-1.24 3.88E-9 Arl1 2.89 3.43E-8 2.99 6.8E-8 2.92 1.62E-8 Arl3 1.17 6.69E-7 1.3 7.52E-7 1.2 3.87E-7 Arl4d -1.57 1.42E-3-1.29 1.7E-2-1.63 9.81E-4 Arl5b -2.8 8.98E-7-2.53 5.1E-7-2.67 8.E-8 Arl8b -1.19 2.39E-7-1.37 2.26E-7-1.41 4.2E-8 Armc3.8 3.15E-3 1.54 5.2E-5 1.59 1.24E-5 Armcx1 -.9 2.88E-3-1.16 1.11E-3-1.9 6.52E-6 Armcx4-2.29 1.27E-5-2.8 6.39E-6-4.27 5.E-8 Armcx5-1.58 4.3E-4-1.78 4.19E-4-2.29 1.72E-5 Armcx6-1.1 1.7E-3-1.15 1.52E-3-1.7 2.28E-5 Arntl2 1.88 9.46E-3 1.91 1.64E-2 1.61 2.11E-2 Arpc1a -.94 9.42E-9-1.3 1.33E-8-1.11 1.28E-9 Arrdc3-1. 2.1E-6-1.1 2.49E-6-1.1 6.69E-7

Arsk 1.51 4.44E-7 1.58 8.23E-7 2. 3.3E-8 Art2b 2.45 8.3E-9 3.13 5.57E-9 4.48 7.35E-11 Art5-1.47 2.41E-2-1.87 1.22E-2-2.18 2.4E-3 Asah1 1.3 6.13E-9 1.4 1.33E-8 1.2 2.43E-9 Ascl3 1.33 2.14E-3 1.71 8.13E-4 1.8 1.98E-4 Asf1a -1.7 1.18E-4-1.46 2.34E-5-1.4 1.3E-4 Asgr1-1.96 1.8E-2-1.87 3.93E-2-3.23 6.32E-4 Aspm -2.3 2.8E-5-2.4 5.34E-5-2.63 7.39E-6 Asrgl1 1.47 4.52E-8 1.59 6.8E-8 1.66 9.77E-9 Atad2-1.87 2.49E-7-2.18 2.13E-7-2.11 6.27E-8 Atad3aos 1.15 4.69E-4 1.7 1.87E-3 1.36 1.7E-4 Atad5-1.92 5.2E-7-2.2 4.84E-7-3.37 4.53E-9 Atcay -1.1 9.1E-3-1.37 2.64E-3-1.56 4.5E-4 Atf1 -.96 1.18E-7-1.7 1.47E-7-1.9 2.71E-8 Atf3-3.12 2.45E-4-4.49 3.27E-5-4.84 5.27E-6 Atf4-1.5 9.22E-7-1.13 1.35E-6-1.35 8.24E-8 Atf5 -.88 3.2E-3-1.18 9.7E-4-1.3 9.67E-4 Atg11-1.3 1.8E-6-1.27 5.65E-7-1.16 3.2E-7 Atg14-1.28 3.98E-8-1.39 5.6E-8-1.11 6.22E-8 Atg2a -1.2 4.17E-8-1.4 3.98E-8-1.31 1.16E-8 Atg7-1.56 2.9E-8-1.63 5.47E-8-1.49 2.3E-8 Atl2-1.46 3.72E-7-1.69 3.9E-7-1.72 6.66E-8 Atp1a2-2.13 3.83E-5-1.29 4.9E-3-2.41 1.15E-5 Atp6vd1-1.37 2.41E-8-1.47 3.87E-8-1.41 9.8E-9 Atp6ve2-1.48 6.56E-3-1.26 2.99E-2-1.75 1.97E-3 Atp6v1e1-1.41 1.75E-8-1.49 2.97E-8-1.51 4.89E-9 Atp6v1g2 1.4 4.25E-3 1.83 1.52E-4 1.61 1.51E-4 Atp6v1h -1.9 2.E-8-1.17 3.4E-8-1.43 1.42E-9 Atxn7l1os2 1.1 3.67E-8.87 4.96E-7 1.11 1.71E-8 AU226 1.33 2.1E-7 1.52 2.5E-7 1.63 2.71E-8 AU22252.94 1.43E-7 1.6 1.53E-7 1.1 2.68E-8 Aurka -.99 5.58E-3-1.21 3.17E-3-1.15 1.92E-3 AV99323 1.55 1.57E-2 2.7 5.45E-3 2.81 2.38E-4 Avil 1.3 3.42E-5 1.47 3.17E-5 3.7 1.96E-8 Avl9-1.5 2.33E-7-1.71 2.29E-7-1.66 6.71E-8 AW146154 1.96 2.49E-3 2.35 1.59E-3 2.37 5.75E-4 Axl -2.54 2.23E-4-3.12 1.8E-4-2.74 1.6E-4 Azin1-1.34 1.6E-7-1.54 1.47E-7-1.54 3.32E-8

B1334C11Rik 2.62 7.33E-8 2.6 1.98E-7 2.88 2.4E-8 B3galnt2 1.1 3.38E-7 1.18 5.19E-7 1.15 1.63E-7 B3gnt3 1.26 5.82E-4 1.26 1.36E-3 1.76 3.46E-5 B3gnt5 1.12 1.22E-6 1.23 1.54E-6 2.62 1.35E-9 B3gnt7-1.81 9.65E-3-1.85 1.64E-2-1.42 3.29E-2 B3gnt9 1.54 9.11E-4 1.65 1.29E-3 1.61 5.89E-4 B43212C6Rik 1.54 9.26E-4 1.96 3.5E-4 1.84 2.1E-4 B4galt1-1.19 1.54E-8-1.34 1.81E-8-1.29 3.88E-9 B6319A1Rik 1.5 2.93E-7 1.6 7.2E-7 2.48 4.13E-1 Bace1 1.45 1.4E-7 1.8 7.72E-8 1.75 1.96E-8 Bach1-1.26 3.73E-7-1.37 5.15E-7-1.1 8.16E-7 Bach2it1-1.59 3.7E-3-2.5 1.16E-3-1.39 6.75E-3 Bag3-1.4 1.72E-5-1.63 1.36E-5-1.21 5.9E-5 Bag4-1.4 2.89E-5-1.19 2.56E-5-1.12 1.24E-5 Baiap2-1.54 1.38E-7-1.95 6.9E-8-2.6 9.8E-9 Bambi -1.96 7.7E-4-2.45 3.9E-4-2.99 1.94E-5 Banp 1.2 7.31E-6 1.8 4.85E-5 1.41 1.49E-6 Bap1-1.3 3.19E-8-1.5 7.19E-8-1.4 1.48E-8 Basp1-1.13 3.45E-5-1.38 1.63E-5-1.51 2.23E-6 Batf -1.44 1.98E-5-1.66 1.68E-5-1.59 7.27E-6 Bbs1 1.45 2.48E-7 1.29 1.76E-6 2.2 1.22E-8 BC17158 1.12 2.64E-7 1.3 1.41E-6 1.2 4.5E-7 BC2592 1.97 1.1E-6 2.9 1.88E-6 2.57 8.62E-8 BC3499 1.12 8.83E-4 1.33 6.E-4 1.53 6.63E-5 BC49352 1.64 3.94E-4 2.28 7.22E-5 1.1 1.E-2 BC51226 1.37 2.19E-6 1.61 1.59E-6 1.93 8.68E-8 BC68281 1.26 5.1E-7 1.64 1.82E-7 1.37 1.78E-7 BC94916 1.25 7.45E-8 1.42 7.75E-8 2.6 2.79E-1 BC16179 1.9 2.16E-2 1.94 3.4E-2 3.38 4.54E-4 BC147527 2.8 7.26E-7 2.6 3.36E-7 3.15 1.76E-8 Bcar1-2.29 1.39E-2-3.96 8.2E-4-2.86 3.21E-3 Bcat1-2.24 2.4E-3-2.72 1.37E-3-3.4 2.18E-4 Bcl1-1.51 1.8E-7-1.66 1.41E-7-1.69 2.64E-8 Bcl2a1a -1.7 3.58E-3-1.62 9.82E-3-1.97 1.16E-3 Bcl2a1b -2.31 1.45E-7-2.89 7.7E-8-2.86 1.68E-8 Bcl2l11-1.8 8.57E-9-1.9 1.96E-8-1.94 8.35E-11 Bcl2l12 1.44 1.66E-6 1.22 1.76E-5 1.27 3.84E-6 Bcl2l13-1.32 2.96E-8-1.47 3.83E-8-1.6 3.77E-9

Bcl2l15 1.46 2.71E-3 1.55 3.92E-3 1.97 2.56E-4 Bdkrb1 2. 5.79E-3 1.62 3.43E-2 1.98 5.65E-3 BE6927 1.58 5.62E-8 1.94 3.73E-8 2.82 5.48E-1 Bend3-2.1 4.12E-8-2.43 4.22E-8-3.5 1.56E-9 Bend4-2.87 1.84E-5-4.13 2.36E-6-3.39 3.57E-6 Bend5-2.8 4.23E-3-1.85 1.68E-2-2.46 1.24E-3 Bhlha15.59 9.49E-4 1.45 1.78E-6 1.1 1.14E-5 Bhlhe4-2.64 5.37E-7-3.6 1.36E-7-3.92 1.54E-8 Bhlhe41-3.43 6.96E-5-4.55 1.74E-5-5.26 1.45E-6 Bin2 1.17 9.14E-9 1.26 1.44E-8 1.4 8.28E-9 Blm -1.81 2.41E-7-2.5 2.47E-7-2.3 6.35E-8 Bloc1s3 1.13 3.53E-7 1.6 1.69E-6 1.4 4.36E-8 Blvrb 1.2 9.39E-4.79 1.8E-2 1.54 2.89E-5 Bmp2k -1.53 2.7E-7-1.56 4.66E-7-1.66 7.7E-8 Bpgm -1.57 1.12E-6-1.67 1.85E-6-1.39 2.44E-6 Bpnt1-1.4 7.13E-7-1.84 2.31E-7-1.82 5.92E-8 Brat1 1.2 5.6E-9 1.8 8.67E-9 1.21 6.16E-1 Brca1-1.54 2.83E-5-1.65 4.23E-5-1.11 3.42E-4 Brms1l.99 3.17E-7 1.2 1.9E-7 1.26 3.E-8 Bsdc1-1.32 2.41E-8-1.52 2.43E-8-1.55 3.65E-9 Btaf1-1.4 3.1E-8-1.4 7.36E-8-1.13 7.9E-9 Btbd1-1.5 2.32E-6-1.7 5.33E-6-1.27 3.39E-7 Btg1-1.22 1.24E-6-1.45 8.56E-7-1.18 1.26E-6 Btg2-1.21 1.24E-6-1.43 8.39E-7-1.6 2.91E-6 Btg3-1.2 1.31E-6-1.3 1.86E-6-1.79 3.31E-8 Btnl7-ps 1.82 3.35E-5 1.66 1.88E-4 3.11 2.72E-7 Bud31-1.12 4.6E-7-1.24 5.48E-7-1.31 8.69E-8 Bzw2-1.3 4.31E-8-1.41 6.55E-8-1.98 1.2E-9 C339L3Rik.94 2.5E-6 1.1 3.8E-6 1.18 2.18E-7 C1336L24Rik 1.89 3.98E-8 2.8 5.25E-8 2.8 1.1E-8 C1346K22Rik 1.21 1.2E-4 1.17 3.25E-4 1.51 1.36E-5 C1qtnf9 1.28 6.17E-3 2.1 5.89E-4 1.33 4.39E-3 C2337L18Rik 1.93 5.65E-8 1.77 2.69E-7 2.13 1.49E-8 C2338L3Rik -2.49 6.44E-5-2.55 1.39E-4-3.7 1.79E-6 C2362I16Rik 2.41 3.95E-5 2.93 2.1E-5 2.48 2.55E-5 C2cd2 1.12 2.41E-7 1.2 1.42E-6 1.2 3.7E-7 C3318D2Rik.93 3.39E-6 1.3 4.3E-6 1.52 4.14E-8 C3327C9Rik -2.57 1.95E-4-3.34 5.96E-5-3.42 1.53E-5

C432N11Rik -2.85 8.14E-5-1.22 4.53E-2-1.26 2.8E-2 C778-1.79 1.67E-4-1.4 1.5E-2-1.74 1.77E-4 C929B18Rik -2.58 2.5E-4-2.4 8.67E-4-2.83 8.39E-5 C9225E4Rik 1.17 3.76E-6 1.12 1.41E-5 1.39 6.3E-7 Cabp4.78 3.36E-2 1.5 1.35E-3 1.42 7.94E-4 Cacna2d4 1.79 6.3E-9 1.78 1.41E-8 2.2 5.47E-1 Cacnb3 1.14 6.72E-5.72 4.96E-3 2.23 1.72E-7 Calca -1.81 2.57E-4-1.96 3.45E-4-2.9 7.18E-5 Calm2-1.2 1.84E-7-1.9 3.9E-7-1.16 4.22E-8 Camk2n1.93 4.24E-4 1.38 4.53E-5 1.13 8.16E-5 Camsap2-1.53 4.52E-8-1.74 4.88E-8-1.99 3.62E-9 Car11 1.33 8.95E-5.9 4.1E-3 1.36 6.44E-5 Card9 1.2 1.72E-6.84 8.85E-5 1.9 3.6E-6 Carhsp1-1. 1.75E-7-1.17 1.42E-7-1.8 5.98E-8 Carns1 1.3 1.95E-8 1.28 5.9E-8 1.79 9.76E-1 Casc4-1.67 3.66E-7-1.87 4.2E-7-2.39 1.47E-8 Casc5-2.7 8.82E-6-2.9 2.19E-5-1.67 4.45E-5 Casp3-1.26 4.41E-6-1.3 9.1E-6-1.99 6.87E-8 Casp9 1.6 1.52E-8 1.56 4.27E-8 1.61 6.28E-9 Cass4 1.2 1.44E-2.98 3.7E-2 1.76 3.15E-4 Casz1-2.1 1.8E-7-2.48 6.52E-8-2.14 4.4E-8 Cbx5 1.47 8.1E-9 1.59 1.22E-8 1.52 2.43E-9 Ccbl1 1.17 3.53E-7 1.4 2.51E-6 1.2 7.93E-7 Ccdc11 1.5 4.79E-7 1.14 6.93E-7 1.23 8.67E-8 Ccdc16.98 3.85E-2 1.36 1.31E-2 1.58 2.34E-3 Ccdc17 1.7 1.97E-6 1.4 6.75E-6 1.3 2.16E-6 Ccdc117-1.96 3.97E-7-2.35 2.56E-7-2.23 9.19E-8 Ccdc136 1.78 2.24E-2 2.16 1.46E-2 1.52 4.5E-2 Ccdc163 1.32 1.72E-6 1.52 1.44E-6 1.58 2.83E-7 Ccdc167 1.68 4.45E-4 1.91 4.2E-4 1.57 6.51E-4 Ccdc175 1.6 3.51E-3 2.55 2.65E-4 1.3 1.16E-2 Ccdc18 1.6 5.82E-4.65 2.7E-2 1.33 8.87E-5 Ccdc181.89 1.4E-3 1.9 5.56E-4 1.72 4.1E-6 Ccdc186-1.9 9.7E-7-1.12 1.93E-6-1.14 4.37E-7 Ccdc39 1.18 4.37E-4 2.2 6.97E-6 1.81 1.1E-5 Ccdc51 1.1 3.1E-5 1.16 2.66E-5 1.1 1.27E-5 Ccdc73 1.35 3.26E-5 2.8 2.38E-6 1.79 2.42E-6 Ccdc8-2.3 2.6E-2-2.19 3.16E-2-2.28 1.33E-2

Ccdc86 -.98 5.35E-6-1.8 6.19E-6-1.44 1.5E-7 Ccin 1.93 4.34E-3 3.36 1.76E-4 1.25 4.36E-2 Ccnb2 2.11 3.78E-4 2.69 1.41E-4 2.9 2.4E-5 Ccne1 2.2 3.1E-8 1.96 1.63E-7 2.5 6.22E-9 Ccne2-2.16 2.46E-5-2.74 9.1E-6-2.78 2.31E-6 Ccnk -1.17 2.37E-8-1.26 3.62E-8-1.23 7.94E-9 Ccno -1.92 6.15E-3-1.99 9.74E-3-2.73 4.68E-4 Ccnt1-1.23 6.5E-8-1.37 8.28E-8-1.35 1.83E-8 Ccnyl1-1.37 1.1E-6-1.54 1.17E-6-1.7 1.31E-7 Ccpg1-1.41 1.43E-7-1.7 9.92E-8-1.17 4.46E-7 Ccr2-1.11 1.32E-3-1.24 1.35E-3-1.64 5.32E-5 Ccr4-1.9 1.14E-4-2.6 1.55E-4-3.53 4.65E-7 Ccr7-1.54 1.92E-8-1.84 1.6E-8-2.18 7.94E-1 Ccr8-3.9 6.53E-4-4.58 7.31E-5-5.81 2.9E-6 Ccrl2-1.89 1.19E-3-2.18 9.83E-4-1.55 4.17E-3 Cd164l2-3.7 1.4E-5-2.69 1.12E-4-4.54 3.85E-7 Cd2r1 1.62 4.53E-8 2.23 1.6E-8 1.56 3.43E-8 Cd24a -2.42 7.32E-5-3.42 1.9E-5-3.88 1.5E-6 Cd44-1.83 5.85E-7-2.2 3.59E-7-2.37 4.72E-8 Cd46 1.41 5.24E-7 1.45 1.15E-6 2. 2.13E-8 Cd47 1.17 2.83E-9 1.19 6.5E-9 1.21 7.8E-1 Cd48 1.75 1.4E-9 1.89 1.36E-9 1.27 1.57E-9 Cd69-3.12 4.E-5-4.27 7.72E-6-4.57 1.22E-6 Cd7 1.11 9.6E-5 1.51 1.88E-5 1.76 1.43E-6 Cd83-2.22 1.45E-4-2.79 5.79E-5-2.9 1.3E-5 Cd86-2.51 1.89E-6-2.95 1.35E-6-1.74 3.47E-5 Cd9.99 1.9E-6 1.11 1.17E-6 1.79 7.11E-9 Cdc2 -.98 9.94E-5-1.34 2.6E-5-1.32 6.96E-6 Cdc25b 2.18 5.89E-9 1.95 2.61E-8 2.96 3.E-1 Cdc27-1.27 1.73E-7-1.33 3.24E-7-1.51 2.89E-8 Cdc42se1 1.14 7.9E-1 1.26 1.11E-9 1.33 6.69E-11 Cdc45-1.6 8.77E-5-1.3 1.1E-3-1.85 2.17E-5 Cdca2-1.37 3.5E-5 -.91 1.84E-3-1.63 5.59E-6 Cdh1-3.11 2.57E-4-3.5 7.28E-4-3.41 1.8E-4 Cdh23 1.12 1.6E-6.94 1.91E-5 1.8 2.28E-8 Cdh24-1.7 2.57E-6 -.92 2.43E-5-1.24 5.72E-7 Cdk11b -1.5 3.1E-8-1.75 2.94E-8-1.78 4.43E-9 Cdk17-1.9 4.36E-8-1.25 4.55E-8-1.4 3.4E-8

Cdkn1a -3.16 1.98E-4-4.7 6.5E-5-5.15 2.6E-6 Cdkn2aip -1.11 2.29E-7-1.11 6.55E-7-1.9 1.81E-7 Cdo1.75 3.29E-2 1.27 3.17E-3 1.34 8.92E-4 Cdpf1 1.38 2.53E-7 1.18 2.54E-6 1.76 2.44E-8 Cdt1-1.35 5.72E-7-1.63 3.42E-7-1.8 3.66E-8 Ceacam1-1.38 9.48E-3-2.4 4.7E-4-1.1 2.91E-2 Cebpa -1.9 2.81E-2-2.62 1.84E-4-1.89 8.35E-4 Cecr6-1.13 3.18E-3-1.69 3.87E-4-1.43 5.35E-4 Celf3 1.84 2.6E-5 2.5 2.84E-5 2.38 2.35E-6 Cenpc1 -.99 4.43E-8-1. 9.87E-8-1.61 7.67E-1 Cenpe -1.99 1.29E-5-2.46 5.87E-6-1.91 1.53E-5 Cenpi -1.53 6.33E-4-1.86 3.49E-4-1.65 3.8E-4 Cenpl -2.1 1.4E-6-2.53 4.34E-7-2.69 6.34E-8 Cenpq -1.27 1.42E-6-1.17 7.69E-6-1.22 1.6E-6 Cenpw -1.47 1.69E-3-1.59 2.12E-3-1.58 8.93E-4 Cep12-1.35 1.6E-7-1.45 1.64E-7-1.34 6.73E-8 Cep19 1.11 1.84E-5.78 8.15E-4 1.16 1.9E-5 Cep55-2.32 2.39E-4-1.95 2.1E-3-2.8 4.93E-4 Cep57 -.97 1.42E-6-1.1 1.46E-6-1.6 5.35E-7 Cep68 1.5 5.76E-9 1.1 9.54E-9 1.27 5.48E-1 Cep76-1.3 4.2E-6-1.2 3.14E-6-1.23 6.78E-7 Cep83os.8 7.41E-5 1.14 1.1E-5 1.34 6.94E-7 Cep85l -1.4 7.86E-7-1.6 7.15E-7-1.47 3.81E-7 Cfap43 -.97 7.1E-9-1.31 3.71E-9-1.7 1.36E-9 Cfap97.97 1.86E-7 1.2 3.35E-7 1.34 9.98E-9 Chaf1a -2.39 5.16E-4-3.18 1.33E-4-3.33 2.95E-5 Chd1-1.7 1.51E-7-1.16 2.6E-7-1.8 8.46E-8 Chd2-1.42 4.72E-8-1.47 9.42E-8-1.22 8.63E-8 Chd7-1.85 3.95E-8-2.9 4.51E-8-1.98 1.24E-8 Chdh -1.37 1.46E-5-1.65 8.21E-6-1.9 6.84E-7 Chek1-1.76 7.79E-5-2.37 1.73E-5-2.71 1.59E-6 Chek2 1.93 1.8E-7 1.91 2.96E-7 1.88 8.E-8 Chka -1.86 4.5E-6-2.39 1.38E-6-2.78 9.95E-8 Chl1-3.46 2.29E-4-2.75 2.88E-3-4.84 1.18E-5 Chn2-2.2 3.59E-5-2.41 2.14E-5-2.23 1.3E-5 Chrm3-2.25 1.5E-2-3.12 4.19E-3-2.69 4.81E-3 Chrna2-2.22 5.37E-4-2.31 9.29E-4-2.32 3.41E-4 Chrnb1 1.4 2.62E-5 1.15 3.2E-5 1.13 1.6E-5

Chrnb2 1.7 8.1E-7 1.3 3.28E-6 1.28 1.33E-7 Chrne -1.81 2.75E-4-3.25 5.89E-6-2.24 4.15E-5 Chst12 1.66 8.83E-7 1.75 1.57E-6 1.59 9.11E-7 Chst2-3.7 5.55E-3-4.77 5.75E-4-6.98 8.26E-6 Ciart -2.86 3.78E-3-3.39 2.59E-3-5.43 2.31E-5 Cir1-1.16 6.19E-7-1.21 1.16E-6-1.3 1.26E-6 Cirh1a -1.11 5.68E-8-1.23 7.67E-8-1.44 4.91E-9 Cited1-1.42 1.22E-2-1.71 8.5E-3-1.36 1.44E-2 Cited2-1.47 1.66E-6-1.79 9.6E-7-1.62 5.64E-7 Ckap2-1.95 1.68E-6-2.25 1.42E-6-3.7 2.82E-8 Ckap2l -2.24 1.34E-4-2.85 4.86E-5-2.69 2.44E-5 Ckb -.96 1.68E-5-1.39 2.4E-6-1.89 4.2E-8 Cks2-2.6 3.79E-5-2.29 4.13E-5-4.4 9.31E-8 Clcf1.97 3.37E-8 1.6 4.55E-8 1.15 5.8E-9 Cldn4 1.91 9.8E-4 1.86 2.54E-3 1.7 3.8E-2 Cldnd1 -.96 2.36E-7-1.1 2.19E-7-1.15 3.62E-8 Cltc -1.41 4.6E-8-1.53 6.82E-8-1.67 7.17E-9 Cmah 1.51 7.84E-1 1.54 1.27E-9 2.4 2.23E-11 Cnbp -1.8 4.36E-8-1.14 7.58E-8-1.18 1.15E-8 Cnga1 2.73 6.4E-9 2.9 1.E-8 3.67 3.29E-1 Cnksr3-1.18 7.92E-9-1.38 8.39E-9-1.22 2.33E-9 Cnnm4-1.29 1.64E-6-1.69 4.86E-7-1.48 3.62E-7 Cnot6-1.2 7.99E-8-1.18 2.39E-7-1.24 3.72E-8 Cnp 1.42 4.7E-9 1.5 8.39E-9 1.61 6.79E-1 Cnst -1.32 1.4E-8-1.39 2.43E-8-1.41 3.73E-9 Coa7-1.1 8.55E-6-1.25 3.88E-6-1.1 3.23E-6 Coasy 1.31 6.68E-6 1.54 4.59E-6 1.67 6.3E-7 Cobll1-2.35 3.88E-4-1.73 7.33E-3-2.82 7.86E-5 Col11a2 1.22 2.96E-8 1.3 4.71E-8 1.51 3.17E-9 Col23a1.96 1.8E-4 1.21 4.15E-5 1.54 1.61E-6 Colq -2.75 9.65E-5-2.46 5.64E-4-2.44 2.21E-4 Cops2 -.97 1.75E-6-1.6 2.45E-6-1.14 3.38E-7 Cops8-1.11 1.59E-8-1.14 3.26E-8-1.18 4.42E-9 Coq1b -2.55 2.4E-6-3.8 1.17E-6-3.52 9.8E-8 Coq3 1.3 7.3E-7.93 4.66E-6 1.2 5.68E-7 Coq4 1.2 1.43E-4 1.1 6.79E-4 1.41 3.34E-5 Coq7-1.28 4.74E-4-1.81 7.57E-5-1.65 5.43E-5 Corin 1.3 7.52E-4 1.15 7.89E-4 1.25 1.49E-4